A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants

HVTN 117/ HPX2004/ IPCAVD011/ TRAVERSE

HVTN 115/ EnvSeq-1 and CH505

HVTN 124/ PDPHV-201401

HVTN 705 / HPX2008 / CR108263/ Imbokodo

HVTN 119/ p24CE1/2 pDNA

HVTN 706/ HPX3002/ Mosaico

IAVI G002

HVTN 120/ ALVAC-HIV

PrEPVacc / PV1